BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4369675)

  • 1. [Studies on platelet aggregation inhibitory agents (author's transl)].
    Ukita M; Kitahara T; Hosokawa T; Kato M; Suzuki Y; Otomo H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):161-5. PubMed ID: 4369675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation and cyclic AMP].
    Ukita M
    Rinsho Byori; 1972 Nov; 20(11):805-9. PubMed ID: 4347154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nicotine on human blood platelet aggregation.
    Brinson K
    Atherosclerosis; 1974; 20(1):137-40. PubMed ID: 4458691
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cyclic AMP in platelet function.
    Cole B; Robison GA; Hartmann RC
    Ann N Y Acad Sci; 1971 Dec; 185():477-87. PubMed ID: 4330513
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic AMP and platelet aggregation.
    Hugues J
    Acta Univ Carol Med Monogr; 1972; 53():179-84. PubMed ID: 4364682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].
    Scholz Ch; Losert W; Hoder A
    Arzneimittelforschung; 1975 Jan; 25(1):38-46. PubMed ID: 167791
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cyclic AMP in platelet function.
    Salzman EW; Weisenberger H
    Adv Cyclic Nucleotide Res; 1972; 1():231-47. PubMed ID: 4353170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prostaglandin E1 on in vitro and in vivo platelet aggregation with special reference to thrombus formation (author's transl)].
    Kobayashi N; Araki H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):166-73. PubMed ID: 4471800
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet aggregation. 3. An epinephrine induced decrease in cyclic AMP synthesis.
    Marquis NR; Becker JA; Vigdahl RL
    Biochem Biophys Res Commun; 1970 Jun; 39(5):783-9. PubMed ID: 4316427
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of epinephrine, prostaglandins, and their antagonists on adenosine cyclic 3',5'-monophosphate concentrations and motility of the rat uterus.
    Vesin MF; Harbon S
    Mol Pharmacol; 1974 May; 10(3):457-73. PubMed ID: 4369301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface-immobilized prostaglandin as a platelet protective agent.
    Grode GA; Pitman J; Crowley JP; Leininger RI; Falb RD
    Trans Am Soc Artif Intern Organs; 1974; 20A():38-41. PubMed ID: 4375330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperaggregability of platelet in acute stage of thrombosis (author's transl)].
    Yamazaki H; Takahashi T; Mashimo N
    Rinsho Ketsueki; 1973 Dec; 14(0):1365-71. PubMed ID: 4807611
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of prostaglandins E1 and E2 on platelet aggregation in mammals.
    Sinakos Z; Zamboulis C; Kartalis G; Koratzis J; Valtis D
    Haematologica; 1974 Jun; 59(2):173-80. PubMed ID: 4216529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of elastase on platelet adhesiveness and platelet aggregation (author's transl)].
    Kobayashi T; Sakaki H; Toyoshima H; Fujita S; Uesugi S; Endo Y; Satoh M
    Rinsho Byori; 1981 Mar; 29(3):295-8. PubMed ID: 6911161
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phentolamine and propranolol an alpha and beta receptor blocking agent, on epinephrine and ADP induced platelet factor 3, platelet acid phosphatase availability and platelet factor 4 release.
    Kubisz P
    Acta Univ Carol Med Monogr; 1972; 53():79-90. PubMed ID: 4670758
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of platelet aggregation by isochinoline derivatives.
    Markwardt F
    Acta Univ Carol Med Monogr; 1972; 52():79-82. PubMed ID: 4361263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of platelet aggregation and its clinical use (author's transl)].
    Cepelák V
    Cas Lek Cesk; 1974 Jan; 113(2):51-5. PubMed ID: 4154807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.